Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
- PMID: 19032450
- DOI: 10.1111/j.1440-1746.2008.05640.x
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
Abstract
Background and aim: Ethnic differences in non-alcoholic steatohepatitis (NASH) are well-documented, but there has been no study on the prognosis of Japanese NASH patients with cirrhosis. Accordingly, we compared cirrhotic NASH with liver cirrhosis caused by chronic hepatitis C (LC-C) to clarify its clinical features and define the risk factors for death.
Methods: A prospective evaluation of the outcomes of NASH patients with severe fibrosis was started in 1990. Data on age- and sex-matched patients with biopsy-proven LC-C were collected retrospectively and used as the control.
Results: There were 68 patients with cirrhotic NASH and 69 with LC-C. The Child-Turcotte-Pugh (CTP) class was similar in these two groups. Although the outcome of the NASH group was better than that of the LC-C group, cirrhotic NASH followed a similar course to that of LC-C; that is, complications of cirrhosis developed, including hepatocellular carcinoma (HCC; the 5-year HCC rate was 11.3% for NASH and 30.5% for HCV) and death (the 5-year survival rates were 75.2% and 73.8%, respectively). HCC was the leading cause of death in both groups (NASH, 47%; HCV, 68%). The occurrence of HCC and the CTP class were significant risk factors for mortality in NASH patients according to a multivariate analysis (HCC: hazard ratio [HR] 7.96, 95% confidence interval [CI] 2.45-25.88, CTP class A: HR 0.17, 95% CI 0.06-0.50).
Conclusion: In conclusion, the present study confirmed that cirrhotic NASH has a similar course to LC-C. The occurrence of HCC was the strongest predictor of mortality in the NASH groups. These findings may be helpful when deciding on therapeutic interventions for NASH and also for the daily management of these patients.
Similar articles
-
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa. Am J Surg Pathol. 2010. PMID: 20975341
-
Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis.J Gastroenterol Hepatol. 2009 Jul;24(7):1276-83. doi: 10.1111/j.1440-1746.2009.05851.x. Epub 2009 Apr 6. J Gastroenterol Hepatol. 2009. PMID: 19486451
-
Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.J Gastroenterol. 2010 Sep;45(9):960-7. doi: 10.1007/s00535-010-0237-1. Epub 2010 Apr 8. J Gastroenterol. 2010. PMID: 20376504
-
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239. J Gastroenterol Hepatol. 2013. PMID: 24251711 Review.
-
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.World J Gastroenterol. 2010 Mar 28;16(12):1436-41. doi: 10.3748/wjg.v16.i12.1436. World J Gastroenterol. 2010. PMID: 20333782 Free PMC article. Review.
Cited by
-
Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis.World J Hepatol. 2022 Jul 27;14(7):1277-1290. doi: 10.4254/wjh.v14.i7.1277. World J Hepatol. 2022. PMID: 36158907 Free PMC article. Review.
-
The Natural Course of Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2016 May 20;17(5):774. doi: 10.3390/ijms17050774. Int J Mol Sci. 2016. PMID: 27213358 Free PMC article. Review.
-
Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms.Cancers (Basel). 2023 Jan 25;15(3):729. doi: 10.3390/cancers15030729. Cancers (Basel). 2023. PMID: 36765688 Free PMC article. Review.
-
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17. Indian J Med Res. 2019. PMID: 31115369 Free PMC article. Review.
-
Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges.J Hepatocell Carcinoma. 2022 Jun 1;9:477-496. doi: 10.2147/JHC.S344559. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 35673598 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical